Literature DB >> 33599882

Advanced imaging techniques for neuro-oncologic tumor diagnosis, with an emphasis on PET-MRI imaging of malignant brain tumors.

Wynton B Overcast1, Korbin M Davis1, Chang Y Ho2, Gary D Hutchins3, Mark A Green3, Brian D Graner2, Michael C Veronesi4.   

Abstract

PURPOSE OF REVIEW: This review will explore the latest in advanced imaging techniques, with a focus on the complementary nature of multiparametric, multimodality imaging using magnetic resonance imaging (MRI) and positron emission tomography (PET). RECENT
FINDINGS: Advanced MRI techniques including perfusion-weighted imaging (PWI), MR spectroscopy (MRS), diffusion-weighted imaging (DWI), and MR chemical exchange saturation transfer (CEST) offer significant advantages over conventional MR imaging when evaluating tumor extent, predicting grade, and assessing treatment response. PET performed in addition to advanced MRI provides complementary information regarding tumor metabolic properties, particularly when performed simultaneously. 18F-fluoroethyltyrosine (FET) PET improves the specificity of tumor diagnosis and evaluation of post-treatment changes. Incorporation of radiogenomics and machine learning methods further improve advanced imaging. The complementary nature of combining advanced imaging techniques across modalities for brain tumor imaging and incorporating technologies such as radiogenomics has the potential to reshape the landscape in neuro-oncology.

Entities:  

Keywords:  Advanced MRI; Amino acid PET; Brain tumor; Chemical exchange saturation transfer; Diffusion-weighted imaging; FET; Glioblastoma; Glioma; High-grade malignancy; Hybrid PET/MRI; MR spectroscopy; Metastasis; Perfusion-weighted imaging; Progression; Pseudoprogression; Pseudoresponse; Radiation necrosis; Radiogenomics; Radiomics; Treatment-related change; Tumor grading

Mesh:

Year:  2021        PMID: 33599882      PMCID: PMC7892735          DOI: 10.1007/s11912-021-01020-2

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  153 in total

Review 1.  Diffusion tensor imaging of the brain.

Authors:  Andrew L Alexander; Jee Eun Lee; Mariana Lazar; Aaron S Field
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

2.  Prediction of pseudoprogression in patients with glioblastomas using the initial and final area under the curves ratio derived from dynamic contrast-enhanced T1-weighted perfusion MR imaging.

Authors:  C H Suh; H S Kim; Y J Choi; N Kim; S J Kim
Journal:  AJNR Am J Neuroradiol       Date:  2013-07-04       Impact factor: 3.825

3.  Prediction of glioma recurrence using dynamic ¹⁸F-fluoroethyltyrosine PET.

Authors:  T Pyka; J Gempt; F Ringel; S Hüttinger; S van Marwick; S Nekolla; H-J Wester; M Schwaiger; S Förster
Journal:  AJNR Am J Neuroradiol       Date:  2014-06-12       Impact factor: 3.825

4.  Dynamic susceptibility contrast MRI measures of relative cerebral blood volume as a prognostic marker for overall survival in recurrent glioblastoma: results from the ACRIN 6677/RTOG 0625 multicenter trial.

Authors:  Kathleen M Schmainda; Zheng Zhang; Melissa Prah; Bradley S Snyder; Mark R Gilbert; A Gregory Sorensen; Daniel P Barboriak; Jerrold L Boxerman
Journal:  Neuro Oncol       Date:  2015-02-02       Impact factor: 12.300

5.  Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival.

Authors:  Daniel A Hamstra; Craig J Galbán; Charles R Meyer; Timothy D Johnson; Pia C Sundgren; Christina Tsien; Theodore S Lawrence; Larry Junck; David J Ross; Alnawaz Rehemtulla; Brian D Ross; Thomas L Chenevert
Journal:  J Clin Oncol       Date:  2008-06-09       Impact factor: 44.544

6.  Amide proton transfer imaging of adult diffuse gliomas: correlation with histopathological grades.

Authors:  Osamu Togao; Takashi Yoshiura; Jochen Keupp; Akio Hiwatashi; Koji Yamashita; Kazufumi Kikuchi; Yuriko Suzuki; Satoshi O Suzuki; Toru Iwaki; Nobuhiro Hata; Masahiro Mizoguchi; Koji Yoshimoto; Koji Sagiyama; Masaya Takahashi; Hiroshi Honda
Journal:  Neuro Oncol       Date:  2013-12-04       Impact factor: 12.300

7.  Downfield-NOE-suppressed amide-CEST-MRI at 7 Tesla provides a unique contrast in human glioblastoma.

Authors:  Moritz Zaiss; Johannes Windschuh; Steffen Goerke; Daniel Paech; Jan-Eric Meissner; Sina Burth; Philipp Kickingereder; Wolfgang Wick; Martin Bendszus; Heinz-Peter Schlemmer; Mark E Ladd; Peter Bachert; Alexander Radbruch
Journal:  Magn Reson Med       Date:  2016-01-27       Impact factor: 4.668

8.  Management of Glioblastoma, Present and Future.

Authors:  Nancy Ann Oberheim Bush; Shawn L Hervey-Jumper; Mitchel S Berger
Journal:  World Neurosurg       Date:  2019-11       Impact factor: 2.104

Review 9.  Beyond IDH-Mutation: Emerging Molecular Diagnostic and Prognostic Features in Adult Diffuse Gliomas.

Authors:  Kanish Mirchia; Timothy E Richardson
Journal:  Cancers (Basel)       Date:  2020-07-06       Impact factor: 6.639

10.  Super-Resolution Whole-Brain 3D MR Spectroscopic Imaging for Mapping D-2-Hydroxyglutarate and Tumor Metabolism in Isocitrate Dehydrogenase 1-mutated Human Gliomas.

Authors:  Xianqi Li; Bernhard Strasser; Kourosh Jafari-Khouzani; Bijaya Thapa; Julia Small; Daniel P Cahill; Jorg Dietrich; Tracy T Batchelor; Ovidiu C Andronesi
Journal:  Radiology       Date:  2020-01-07       Impact factor: 29.146

View more
  8 in total

1.  Repeatability of image features extracted from FET PET in application to post-surgical glioblastoma assessment.

Authors:  Nathaniel Barry; Pejman Rowshanfarzad; Roslyn J Francis; Anna K Nowak; Martin A Ebert
Journal:  Phys Eng Sci Med       Date:  2021-08-26

Review 2.  A Systematic Review of the Current Status and Quality of Radiomics for Glioma Differential Diagnosis.

Authors:  Valentina Brancato; Marco Cerrone; Marialuisa Lavitrano; Marco Salvatore; Carlo Cavaliere
Journal:  Cancers (Basel)       Date:  2022-05-31       Impact factor: 6.575

3.  Tracking the Corticospinal Tract in Patients With High-Grade Glioma: Clinical Evaluation of Multi-Level Fiber Tracking and Comparison to Conventional Deterministic Approaches.

Authors:  Andrey Zhylka; Nico Sollmann; Florian Kofler; Ahmed Radwan; Alberto De Luca; Jens Gempt; Benedikt Wiestler; Bjoern Menze; Sandro M Krieg; Claus Zimmer; Jan S Kirschke; Stefan Sunaert; Alexander Leemans; Josien P W Pluim
Journal:  Front Oncol       Date:  2021-12-14       Impact factor: 6.244

4.  Integrin α6-Targeted Molecular Imaging of Central Nervous System Leukemia in Mice.

Authors:  Wenbiao Zhang; Yongjiang Li; Guanjun Chen; Xiaochun Yang; Junfeng Hu; Xiaofei Zhang; Guokai Feng; Hua Wang
Journal:  Front Bioeng Biotechnol       Date:  2022-02-23

Review 5.  Brain Tumor Diagnosis Using Machine Learning, Convolutional Neural Networks, Capsule Neural Networks and Vision Transformers, Applied to MRI: A Survey.

Authors:  Andronicus A Akinyelu; Fulvio Zaccagna; James T Grist; Mauro Castelli; Leonardo Rundo
Journal:  J Imaging       Date:  2022-07-22

Review 6.  Somatostatin Receptor Targeted PET-Imaging for Diagnosis, Radiotherapy Planning and Theranostics of Meningiomas: A Systematic Review of the Literature.

Authors:  Luca Filippi; Isabella Palumbo; Oreste Bagni; Orazio Schillaci; Cynthia Aristei; Barbara Palumbo
Journal:  Diagnostics (Basel)       Date:  2022-07-08

Review 7.  Update on the Use of PET/MRI Contrast Agents and Tracers in Brain Oncology: A Systematic Review.

Authors:  Alessio Smeraldo; Alfonso Maria Ponsiglione; Andrea Soricelli; Paolo Antonio Netti; Enza Torino
Journal:  Int J Nanomedicine       Date:  2022-07-29

8.  Biomimetic semiconducting polymer dots for highly specific NIR-II fluorescence imaging of glioma.

Authors:  Xiaoju Men; Xiaorui Geng; Zhe Zhang; Haobin Chen; Meng Du; Zhiyi Chen; Gang Liu; Changfeng Wu; Zhen Yuan
Journal:  Mater Today Bio       Date:  2022-08-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.